Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cyclic vomiting syndrome (CVS), which is defined by recurrent stereotypical episodes of nausea and vomiting, is a relatively-common disabling condition that is associated with migraine headache and mitochondrial dysfunction. Co-enzyme Q10 (Co-Q) is a nutritional supplement that has demonstrated efficacy in pediatric and adult migraine. It is increasingly used in CVS despite the complete lack of studies to demonstrate its value in treatment METHODS: Using an Internet-based survey filled out by subjects with CVS or their parents, the efficacy, tolerability and subject satisfaction in CVS prophylaxis were queried. Subjects taking Co-Q (22 subjects) were compared against those taking amitriptyline (162 subjects), which is the general standard-of-care. RESULTS: Subjects/parents reported similar levels of efficacy for a variety of episode parameters (frequency, duration, number of emesis, nausea severity). There was a 50% reduction in at least one of those four parameters in 72% of subjects treated with amitriptyline and 68% of subjects treated Co-Q. However, while no side effects were reported on Co-Q, 50% of subjects on amitriptyline reported side effects (P = 5 x 10-7), resulting in 21% discontinuing treatment (P = 0.007). Subjects/parents considered the benefits to outweigh the risks of treatment in 47% of cases on amitriptyline and 77% of cases on Co-Q (P = 0.008). CONCLUSION: Our data suggest that the natural food supplement Co-Q is potentially efficacious and tolerable in the treatment of CVS, and should be considered as an option in CVS prophylaxis. Our data would likely be helpful in the design of a double-blind clinical trial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“There were fourteen studies that included 600 adult and pediatric patients.”
From Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) · cites this paper as [19]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Across these studies, 413/600 (70%) of patients reported complete or partial improvement with a decrease in frequency, duration, or severity of CVS symptoms when treated with a TCA, most commonly amitriptyline.”
From Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One retrospective Internet survey compared the efficacy, tolerability, and patient satisfaction of Co‐Q10 (n = 32) with amitriptyline (n = 249) in children with CVS.”
From Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The incidence of side effects with AT varies from 9% to 25% although this did not result in discontinuation of the drug in most studies.”
From Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) · cites this paper as [19]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The prophylactic treatment of CVS with Co‐Q10 showed overall efficacy of 68%, without side effects (0/22).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
(2006) · Cited by 534
ROME III: The Functional Gastrointestinal Disorders
Sheth, A. A. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31804bbe26 · Cited by 489
Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial
Sándor, P. S., Di Clemente, L., Coppola, G., Saenger, U., Fumal, A., Magis, D., Seidel, L., Agosti, R. M., & Schoenen, J. (2005) · Neurology · doi:10.1212/01.wnl.0000151975.03598.ed · Cited by 371 · cited 1×
“Physicians and other health care providers are increasingly recommending Co-Q for the treatment of a wide variety of conditions, including migraine [9], heart failure [10], statin treatment [11], neurodegenerative conditions [12], and primary inborn errors of mitochondrial energy metabolism [13].”
Oxidative Phosphorylation Diseases: Disorders of Two Genomes
Shoffner, J. M., & Wallace, D. C. (1990) · Advances in Human Genetics · doi:10.1007/978-1-4757-9065-8_5 · Cited by 336 · cited 1×
“between complexes 1 or 2 and complex 3 of the mitochondrial respiratory chain [8], and is thus essential for energy metabolism.”
Li, B. U., Lefevre, F., Chelimsky, G. G., Boles, R. G., Nelson, S. P., Lewis, D. W., Linder, S. L., Issenman, R. M., & Rudolph, C. D. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318173ed39 · Cited by 290
Self-citationBeal, M. F. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041772.74810.92 · Cited by 277
Boehnke, C., Reuter, U., Flach, U., Schuh‐Hofer, S., Einhäupl, K. M., & Arnold, G. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00813.x · Cited by 200 · cited 1×
“Additional mitochondrial-targeted dietary supplements have also been used to prevent CVS attacks including L-carnitine, which has demonstrated efficacy in CVS in one small openlabel study [31] (authors’ practice: 100 mg/kg/day divided BID, up to one gram BID or TID), and riboflavin, which has demonstrated efficacy in…”
Cyclic vomiting syndrome in adults
Abell, T. L., Adams, K. A., Boles, R. G., Bousvaros, A., Chong, S. K. F., Fleisher, D. R., Hasler, W. L., Hyman, P. E., Issenman, R. M., Li, B. U. K., et al. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01113.x · Cited by 194 · cited 1×
“frequent episodes and more severe inter-episodic nausea among adults [29], and strong association with the 16519T and 3010A mtDNA polymorphisms only among children [30].”
Self-citationIs cyclic vomiting syndrome related to migraine?
Li, B. U. K., Murray, R. D., Heitlinger, L. A., Robbins, J. L., & Hayes, J. R. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70242-8 · Cited by 185 · cited 4×
“Mitochondrial dysfunction is hypothesized to be a factor in the pathogenesis of both CVS and migraine headache based upon studies utilizing (31)P-MRS [14] in migraine, and in both conditions by decreased respiratory complex enzymology [15-17], disease-associated mitochondrial DNA (mtDNA) sequence variants [18-23], and…”
InfluentialSelf-citation
Research works printed but not linked: 2
- Shimomura T, Kitano A, Marukawa H, Takahashi K: Mutation in platelet mitochondrial gene in patients with migraine. Cephalalgia. 1995, 15 (Suppl 13): 10-
- Couch JR, Bearss C, Verhulst S: Importance of maternal heredity in the etiology of migraine. Neurology. 1986, 36 (Suppl 1): 99-
Cited by
Childhood Functional Gastrointestinal Disorders: Child/Adolescent
Hyams, J. S., Di Lorenzo, C., Saps, M., Shulman, R. J., Staiano, A., & van Tilburg, M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.015 · Cited by 1,362
Frye, R. E., Rose, S., Slattery, J. M., & MacFabe, D. F. (2015) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v26.27458 · Cited by 163
Venkatesan, T., Levinthal, D. J., Tarbell, S. E., Jaradeh, S. S., Hasler, W. L., Issenman, R. M., Adams, K. A., Sarosiek, I., Stave, C. D., Sharaf, R. N., et al. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13604 · Cited by 137
Self-citationResponse to endovascular reperfusion is not time-dependent in patients with salvageable tissue
Lansberg, M. G., Cereda, C. W., Mlynash, M., Mishra, N. K., Inoue, M., Kemp, S. M., Christensen, S., Straka, M., Zaharchuk, G., Marks, M. P., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001853 · Cited by 99
Kumar, N., Bashar, Q., Reddy, N., Sengupta, J., Ananthakrishnan, A., Schroeder, A., Hogan, W. J., & Venkatesan, T. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-52 · Cited by 96
“Genetic differences have been identified in these two groups with mitochondrial DNA (mtDNA) mutations, 16519 T and 3010A being associated with pediatric-onset CVS [2,9-11].”
Background
Metadata
- Authors
- Boles, R. G., Lovett-Barr, M. R., Preston, A., Li, B. U., & Adams, K.
- Affiliations
- Children's Hospital Los Angeles (US)
- Medical College of Wisconsin (US)
- Corresponding author
- Boles, Richard G
- Venue
- BMC Neurology
- Published
- 2010-01-28
- Volume
- 10
- Issue
- 1
- Pages
- 10-10
- ISSN
- 1471-2377 (ISSN-L)
- PMC
- PMC2825193
- OpenAlex
- W2151236550
- Cited by
- 91
- References
- 34
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 6 · 2023: 7 · 2022: 2 · 2021: 4 · 2020: 3 · 2019: 7 · 2018: 10 · 2017: 7 · 2016: 6 · 2015: 9 · 2014: 8 · 2013: 3 · 2012: 6
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Neurology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Health Sciences › Medicine › Surgery › Nausea and vomiting management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Keywords
- cyclic vomiting syndrome, coenzyme Q10, amitriptyline, migraine prophylaxis, dietary supplements, treatment efficacy, tolerability, adverse effects, patient satisfaction, mitochondrial dysfunction
- MeSH terms
- Amitriptyline, Antiemetics, Humans, Parents, Periodicity, Retrospective Studies, Syndrome, Ubiquinone, Vomiting, Treatment Outcome, Patient Satisfaction, Age of Onset, Risk Assessment, Internet
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study. https://app.cochat.ai/papers/10.1186/1471-2377-10-10
- The paper
- Boles, R. G., Lovett-Barr, M. R., Preston, A., Li, B. U., & Adams, K. (2010). Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study. BMC Neurology. https://doi.org/10.1186/1471-2377-10-10
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.